Billionaire Patrick Soon-Shiong is a controversial guy, in biotech and beyond. This news - Republican lawmakers invited to attend an FDA meeting about a drug from his ImmunityBio - ups the ante. Also raises questions about wiggle room with this drug.

The lede here is not for the faint of heart. SharkNinja built a $6 billion empire by designing infomercial-worthy gadgets that go viral on TikTok https://t.co/ISVUCQGJIV via @BW

Damn, Walmart’s new CEO started as an hourly associate. They take promoting from within seriously.

You may be waiting a long time -- and losing -- if you hold out for sales this year: Holiday discounts are expected to be slimmer as tariffs have retailers "between a rock and a hard place."

The holidays won't be so happy this year at Walgreens, which is ending paid holidays including Thanksgiving and Christmas for many store workers as its new private equity owners start cutting costs

Have you wondered by there's a car wash on every corner these days, with more coming? If you're one of the ultrarich, you may see the private jet boom, too. Why? They both qualify for a new 100% write-off under President Trump’s tax overhaul https://t.co/iPsTWGb1jH

Cigna will start doing away with prescription drug rebates in some of its health plans in 2027, a move it says will save patients money at the pharmacy counter. It will certainly change the flow of payments in this multibillion dollar business

Xi’s stranglehold on rare earths gives China unprecedented leverage to win concessions from the US. Sitting in Beijing’s reserve is control over an even more vital supply chain: medicine. That's the nuclear option.

US President Donald Trump says he will immediately halt all trade negotiations with Canada. The reason? An Ontario ad featuring Ronald Reagan. Join the Streisand Effect here! https://t.co/5Cy4maer6e

Read about Nike's whole body approach: The world's largest sportswear company wants to stimulate your brain from your feet -- passing through robot-like legs. The development engine is revving but will it carry the company out of an innovation rut?

The Trump administration approved a less expensive, generic version of the abortion drug mifepristone. https://t.co/cOXB1q7SlR

Taylor Swift adds another billion to double her standing in the three comma club. Taylor’s wealth tops $2 billion ahead of her “The Life of a Showgirl” release https://t.co/xKxRbA1zb3

CDC's got a new mission statement to match the Trump administration's political agenda. It shows the extent to which the historically nonpartisan health agency is being reshaped to align with the worldview of RFK Jr.

President Trumps pick to be Surgeon General will be divesting her family’s tobacco and other holdings if her nomination goes through.

Imagine a +$100 billion payday. Emphasis on DAY (singular) Larry Ellison has become the world’s richest person for the first time, ending Elon Musk’s nearly year-long reign in the top spot.

The latest push for a Nobel Peace Prize for President Donald Trump. Not the area many expected: Pfizer defended the evidence supporting its Covid vaccine in response to Trump’s questioning of drug companies’ transparency around the shots

The Trump administration's "most favored nation" push for pharma is starting to play out, with Lilly raising the list price for its obesity shot in the UK. It could be a rude awakening for folks who expected the upshot to be cheaper medicine in the US https://t.co/0S7OQhtC8z

The FBI redacted President Donald Trump’s name, as well as the names of other prominent public figures, from the Epstein files under privacy exemptions

Trump's One Big Beautiful Bill is a departure from many conservatives' longtime goal of simplifying the tax code. What you'll pay now depend less on how much money you make, and more on how you earn it, where you live and even who you are https://t.co/Y0lpZi1Hjz

The FDA has begun sharing rejection letters sent to pharmaceutical companies when turning down their drug applications. It started with 200 medicines that were subsequently approved. Get more, including an exclusive interview with Makary, here: